## 



## 

## 

|||Page|
|---|---|---|
|Legal and Administrative<br>Information|||
|Trustees'<br>Annual<br>Report|||
|Independent<br>Auditor's|Report to the Members||
|Statement ofFinancial|Activities||
|Balance Sheet|||
|Notes to the Financial|Statements|10|





## 

## 

|Registered|Registered|Charity|Name|Name|The Sydney Driscoll Neuro-Science|The Sydney Driscoll Neuro-Science|Foundation|
|---|---|---|---|---|---|---|---|
|Charity Registration|||Number||1129367|||
|Company||Registration||Number|06606603|||
|Trustees/Directors|||||JA Ferguson|||
||||||N Gurusinghe|||
||||||J Winnard|||
||||||N D Park|||
||||||JEccles|||
|Registered||Office|||7Winckley|Square||
||||||Preston|||
||||||PR1 3JD|||
|Secretary|||||Mr John Andrew Ferguson|||
|Statutory|Auditor||||MHA Moore and Smalley|||
||||||Chartered|Accountants||
||||||Richard House|||
||||||9Winckley|Square||
||||||Preston|||
||||||PR1 3HP|||
|Solicitors|||||Napthens|||
||||||7Winckley|Square||
||||||Preston|||
||||||PR1 3JD|||





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

|FOR THE YEAR ENDED 5|APRIL 2023||||
|---|---|---|---|---|
||||Totalfunds|Total funds|
||||for the year|for the year|
||||ended|ended|
||||5April|5 April|
|||Note|2023f|2022<br>5|
|Income from:|||||
|Donations<br>and legacies<br>Investment<br>income|||1,184<br>25,363<br>33|434<br>24,218<br>8|
|Other income|||||
|Total incoming resources|||26,580|24,660|
|Expenditure<br>on:|||||
|Raising funds<br>Charitable<br>activities|||5,588<br>60,836|5,822<br>44,511|
|Total resources expended|||66,424|50,333|
|Net income/(expenditure)|before investments||(39,844)|(25,673)|
|Net gains<br>/ (losses) on investments|||(38,643)|41,467|
|Net income/(expenditure)|||(78,487)|15,794|
|Reconciliation<br>offunds|||||
|Balance brought<br>forward<br>at 6 April 2022|||846,342|830,548|
|Balance carried forward at 5April 2023|||767,855|846,342|





## 

## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|Incoming resou|rc|es|||||
|---|---|---|---|---|---|---|
||||||Year ended|Year ended|
||||||5April|5April|
||||||2023|2022|
||||||6|f|
|Donations and|legacies||||||
|Donations|||||1,184|434|
|investmentincome|||||||
|M 8 G Investments||Charifund|||10,438|10,842|
|CCLA Investments||COIF|||104|40|
|Blackrock Asset|Management|||Charinco|10,203|9,730|
|Glaxosmithkline|Ordinary||shares|||987|
|Brunner<br>Investment||Trust|||1,075|1,008|
|F&C Investment|Trust||||777|522|
|BBHealthcare<br>Trust|||||1,656|799|
|Scottish Mortgage||Trust|||142|61|
|Schroeder Asian|return||||850||
|Johnson<br>and Johnson|||||118||
|BP Ordinary<br>shares||||||37|
|BMO Commercial||Property|Trust|||192|
||||||25,363|24,218|
|Otherincome|||||||
|Bank interest|||||33||
||||||26,580|24,660|





## 

## 

## 

## 

|Resources expended||||||
|---|---|---|---|---|---|
|||||Year ended|Year ended|
|||||5 April|5April|
|||||2023|2022|
|||||6|K|
|Charitable<br>activities||||||
|Direct costs||||||
|Project funding||||47,819|29,717|
|Library services||||4,387|4,365|
|Lecture fees and expenses|||||1,542|
|||||52,206|35,624|
|Support costs||||||
|Insurance||||472|1,027|
|Accounting<br>and administration||fees||3,521|5,138|
|Bank charges||||42|20|
|Sundry expenses||||1,595|77|
|Admin Fee|||||576|
|Governance<br>-Auditor's|remuneration||(inclusive ofVAT)|3,000|2,049|
|||||8,630|8,887|
|Total charitable activities||||60,836|44,511|
|Cost ofnrising funds||||||
|Investment<br>management|charges|||5,588|5,822|
|||||66,424|50,333|





## 

## 

## 

|5|Investments|Investments|Investments||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||Market|Additions|Sales|Change|in|Market|Cost at|
|||||value at||proceeds|value||value at|5 April|
|||||6 April|||||5April|2023|
|||||2022f|||||2023<br>F||
||M &G Investments||||||||||
||Charifund|||197,370||(41,234)|(10,259)||145,877|95,484|
||Blackrock||Asset||||||||
||Management|||309,302||(25,107)||62|284,257|116,239|
||Charinco||||||||||
||CCLA investments||||||||||
||COIF Charities|||51,730||(51,827)|109||12|12|
||BMO Commercial||||||||||
||Johnson<br>2.45%||& Jonson<br>corporate||49,998||(1,013)||48,985|49,998|
||bond||||||||||
||B runner|Investment||52,500|||||52,500|50,113|
||Trust||||||||||
||F&C|Investment||50,286|||1,276||51,563|50,065|
||Trust||||||||||
||Bellevue|||50,350|||(10,335)||40,015|50,649|
||Healthcare||Trust||||||||
||Scottish||Mortgage|41,280|||(15,576)||25,704|49,663|
||Trust||||||||||
||Schroder||Asian Pic|45,500|||(2,800)||42,700|49,949|
||BPOrdinary<br>Share||||||||||
|||||798,318|49,998|(118,168)|(38,536)||691,613|512,172|






## 

## 

## 

|Year|ended|Year ended|
|---|---|---|
||5April|5April|
||2023|2022|
||6|5|
||2,520|6,793|



## 

## 

## 

|Financia|l<br>instruments||||
|---|---|---|---|---|
||||2023|2022|
||||6|6|
|Carrying|amount offinancial|assets|||
|Measured|at fair value through|net income/expenditure|691,613|798,318|





## 



## 

## 

|||Page|
|---|---|---|
|Legal and Administrative<br>Information|||
|Trustees'<br>Annual<br>Report|||
|Independent<br>Auditor's|Report to the Members||
|Statement ofFinancial|Activities||
|Balance Sheet|||
|Notes to the Financial|Statements|10|





## 

## 

|Registered|Registered|Charity|Name|Name|The Sydney Driscoll Neuro-Science|The Sydney Driscoll Neuro-Science|Foundation|
|---|---|---|---|---|---|---|---|
|Charity Registration|||Number||1129367|||
|Company||Registration||Number|06606603|||
|Trustees/Directors|||||JA Ferguson|||
||||||N Gurusinghe|||
||||||J Winnard|||
||||||N D Park|||
||||||JEccles|||
|Registered||Office|||7Winckley|Square||
||||||Preston|||
||||||PR1 3JD|||
|Secretary|||||Mr John Andrew Ferguson|||
|Statutory|Auditor||||MHA Moore and Smalley|||
||||||Chartered|Accountants||
||||||Richard House|||
||||||9Winckley|Square||
||||||Preston|||
||||||PR1 3HP|||
|Solicitors|||||Napthens|||
||||||7Winckley|Square||
||||||Preston|||
||||||PR1 3JD|||





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

|FOR THE YEAR ENDED 5|APRIL 2023||||
|---|---|---|---|---|
||||Totalfunds|Total funds|
||||for the year|for the year|
||||ended|ended|
||||5April|5 April|
|||Note|2023f|2022<br>5|
|Income from:|||||
|Donations<br>and legacies<br>Investment<br>income|||1,184<br>25,363<br>33|434<br>24,218<br>8|
|Other income|||||
|Total incoming resources|||26,580|24,660|
|Expenditure<br>on:|||||
|Raising funds<br>Charitable<br>activities|||5,588<br>60,836|5,822<br>44,511|
|Total resources expended|||66,424|50,333|
|Net income/(expenditure)|before investments||(39,844)|(25,673)|
|Net gains<br>/ (losses) on investments|||(38,643)|41,467|
|Net income/(expenditure)|||(78,487)|15,794|
|Reconciliation<br>offunds|||||
|Balance brought<br>forward<br>at 6 April 2022|||846,342|830,548|
|Balance carried forward at 5April 2023|||767,855|846,342|





## 

## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|Incoming resou|rc|es|||||
|---|---|---|---|---|---|---|
||||||Year ended|Year ended|
||||||5April|5April|
||||||2023|2022|
||||||6|f|
|Donations and|legacies||||||
|Donations|||||1,184|434|
|investmentincome|||||||
|M 8 G Investments||Charifund|||10,438|10,842|
|CCLA Investments||COIF|||104|40|
|Blackrock Asset|Management|||Charinco|10,203|9,730|
|Glaxosmithkline|Ordinary||shares|||987|
|Brunner<br>Investment||Trust|||1,075|1,008|
|F&C Investment|Trust||||777|522|
|BBHealthcare<br>Trust|||||1,656|799|
|Scottish Mortgage||Trust|||142|61|
|Schroeder Asian|return||||850||
|Johnson<br>and Johnson|||||118||
|BP Ordinary<br>shares||||||37|
|BMO Commercial||Property|Trust|||192|
||||||25,363|24,218|
|Otherincome|||||||
|Bank interest|||||33||
||||||26,580|24,660|





## 

## 

## 

## 

|Resources expended||||||
|---|---|---|---|---|---|
|||||Year ended|Year ended|
|||||5 April|5April|
|||||2023|2022|
|||||6|K|
|Charitable<br>activities||||||
|Direct costs||||||
|Project funding||||47,819|29,717|
|Library services||||4,387|4,365|
|Lecture fees and expenses|||||1,542|
|||||52,206|35,624|
|Support costs||||||
|Insurance||||472|1,027|
|Accounting<br>and administration||fees||3,521|5,138|
|Bank charges||||42|20|
|Sundry expenses||||1,595|77|
|Admin Fee|||||576|
|Governance<br>-Auditor's|remuneration||(inclusive ofVAT)|3,000|2,049|
|||||8,630|8,887|
|Total charitable activities||||60,836|44,511|
|Cost ofnrising funds||||||
|Investment<br>management|charges|||5,588|5,822|
|||||66,424|50,333|





## 

## 

## 

|5|Investments|Investments|Investments||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||Market|Additions|Sales|Change|in|Market|Cost at|
|||||value at||proceeds|value||value at|5 April|
|||||6 April|||||5April|2023|
|||||2022f|||||2023<br>F||
||M &G Investments||||||||||
||Charifund|||197,370||(41,234)|(10,259)||145,877|95,484|
||Blackrock||Asset||||||||
||Management|||309,302||(25,107)||62|284,257|116,239|
||Charinco||||||||||
||CCLA investments||||||||||
||COIF Charities|||51,730||(51,827)|109||12|12|
||BMO Commercial||||||||||
||Johnson<br>2.45%||& Jonson<br>corporate||49,998||(1,013)||48,985|49,998|
||bond||||||||||
||B runner|Investment||52,500|||||52,500|50,113|
||Trust||||||||||
||F&C|Investment||50,286|||1,276||51,563|50,065|
||Trust||||||||||
||Bellevue|||50,350|||(10,335)||40,015|50,649|
||Healthcare||Trust||||||||
||Scottish||Mortgage|41,280|||(15,576)||25,704|49,663|
||Trust||||||||||
||Schroder||Asian Pic|45,500|||(2,800)||42,700|49,949|
||BPOrdinary<br>Share||||||||||
|||||798,318|49,998|(118,168)|(38,536)||691,613|512,172|






## 

## 

## 

|Year|ended|Year ended|
|---|---|---|
||5April|5April|
||2023|2022|
||6|5|
||2,520|6,793|



## 

## 

## 

|Financia|l<br>instruments||||
|---|---|---|---|---|
||||2023|2022|
||||6|6|
|Carrying|amount offinancial|assets|||
|Measured|at fair value through|net income/expenditure|691,613|798,318|





## 



## 

## 

|||Page|
|---|---|---|
|Legal and Administrative<br>Information|||
|Trustees'<br>Annual<br>Report|||
|Independent<br>Auditor's|Report to the Members||
|Statement ofFinancial|Activities||
|Balance Sheet|||
|Notes to the Financial|Statements|10|





## 

## 

|Registered|Registered|Charity|Name|Name|The Sydney Driscoll Neuro-Science|The Sydney Driscoll Neuro-Science|Foundation|
|---|---|---|---|---|---|---|---|
|Charity Registration|||Number||1129367|||
|Company||Registration||Number|06606603|||
|Trustees/Directors|||||JA Ferguson|||
||||||N Gurusinghe|||
||||||J Winnard|||
||||||N D Park|||
||||||JEccles|||
|Registered||Office|||7Winckley|Square||
||||||Preston|||
||||||PR1 3JD|||
|Secretary|||||Mr John Andrew Ferguson|||
|Statutory|Auditor||||MHA Moore and Smalley|||
||||||Chartered|Accountants||
||||||Richard House|||
||||||9Winckley|Square||
||||||Preston|||
||||||PR1 3HP|||
|Solicitors|||||Napthens|||
||||||7Winckley|Square||
||||||Preston|||
||||||PR1 3JD|||





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

|FOR THE YEAR ENDED 5|APRIL 2023||||
|---|---|---|---|---|
||||Totalfunds|Total funds|
||||for the year|for the year|
||||ended|ended|
||||5April|5 April|
|||Note|2023f|2022<br>5|
|Income from:|||||
|Donations<br>and legacies<br>Investment<br>income|||1,184<br>25,363<br>33|434<br>24,218<br>8|
|Other income|||||
|Total incoming resources|||26,580|24,660|
|Expenditure<br>on:|||||
|Raising funds<br>Charitable<br>activities|||5,588<br>60,836|5,822<br>44,511|
|Total resources expended|||66,424|50,333|
|Net income/(expenditure)|before investments||(39,844)|(25,673)|
|Net gains<br>/ (losses) on investments|||(38,643)|41,467|
|Net income/(expenditure)|||(78,487)|15,794|
|Reconciliation<br>offunds|||||
|Balance brought<br>forward<br>at 6 April 2022|||846,342|830,548|
|Balance carried forward at 5April 2023|||767,855|846,342|





## 

## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|Incoming resou|rc|es|||||
|---|---|---|---|---|---|---|
||||||Year ended|Year ended|
||||||5April|5April|
||||||2023|2022|
||||||6|f|
|Donations and|legacies||||||
|Donations|||||1,184|434|
|investmentincome|||||||
|M 8 G Investments||Charifund|||10,438|10,842|
|CCLA Investments||COIF|||104|40|
|Blackrock Asset|Management|||Charinco|10,203|9,730|
|Glaxosmithkline|Ordinary||shares|||987|
|Brunner<br>Investment||Trust|||1,075|1,008|
|F&C Investment|Trust||||777|522|
|BBHealthcare<br>Trust|||||1,656|799|
|Scottish Mortgage||Trust|||142|61|
|Schroeder Asian|return||||850||
|Johnson<br>and Johnson|||||118||
|BP Ordinary<br>shares||||||37|
|BMO Commercial||Property|Trust|||192|
||||||25,363|24,218|
|Otherincome|||||||
|Bank interest|||||33||
||||||26,580|24,660|





## 

## 

## 

## 

|Resources expended||||||
|---|---|---|---|---|---|
|||||Year ended|Year ended|
|||||5 April|5April|
|||||2023|2022|
|||||6|K|
|Charitable<br>activities||||||
|Direct costs||||||
|Project funding||||47,819|29,717|
|Library services||||4,387|4,365|
|Lecture fees and expenses|||||1,542|
|||||52,206|35,624|
|Support costs||||||
|Insurance||||472|1,027|
|Accounting<br>and administration||fees||3,521|5,138|
|Bank charges||||42|20|
|Sundry expenses||||1,595|77|
|Admin Fee|||||576|
|Governance<br>-Auditor's|remuneration||(inclusive ofVAT)|3,000|2,049|
|||||8,630|8,887|
|Total charitable activities||||60,836|44,511|
|Cost ofnrising funds||||||
|Investment<br>management|charges|||5,588|5,822|
|||||66,424|50,333|





## 

## 

## 

|5|Investments|Investments|Investments||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||Market|Additions|Sales|Change|in|Market|Cost at|
|||||value at||proceeds|value||value at|5 April|
|||||6 April|||||5April|2023|
|||||2022f|||||2023<br>F||
||M &G Investments||||||||||
||Charifund|||197,370||(41,234)|(10,259)||145,877|95,484|
||Blackrock||Asset||||||||
||Management|||309,302||(25,107)||62|284,257|116,239|
||Charinco||||||||||
||CCLA investments||||||||||
||COIF Charities|||51,730||(51,827)|109||12|12|
||BMO Commercial||||||||||
||Johnson<br>2.45%||& Jonson<br>corporate||49,998||(1,013)||48,985|49,998|
||bond||||||||||
||B runner|Investment||52,500|||||52,500|50,113|
||Trust||||||||||
||F&C|Investment||50,286|||1,276||51,563|50,065|
||Trust||||||||||
||Bellevue|||50,350|||(10,335)||40,015|50,649|
||Healthcare||Trust||||||||
||Scottish||Mortgage|41,280|||(15,576)||25,704|49,663|
||Trust||||||||||
||Schroder||Asian Pic|45,500|||(2,800)||42,700|49,949|
||BPOrdinary<br>Share||||||||||
|||||798,318|49,998|(118,168)|(38,536)||691,613|512,172|






## 

## 

## 

|Year|ended|Year ended|
|---|---|---|
||5April|5April|
||2023|2022|
||6|5|
||2,520|6,793|



## 

## 

## 

|Financia|l<br>instruments||||
|---|---|---|---|---|
||||2023|2022|
||||6|6|
|Carrying|amount offinancial|assets|||
|Measured|at fair value through|net income/expenditure|691,613|798,318|